The Company is developing innovative, implantable devices that repair heart valve abnormalities.  MitralSolutions believes that there are substantial market opportunities in both the surgical and percutaneous applications and is developing a product portfolio that will address treating a greater number of patients earlier in their disease cycle, providing an improved quality of life.